ArticleCureus2025

Effectiveness of Empagliflozin-Linagliptin Fixed-Dose Combination on Chronic Kidney Disease Outcomes in Patients With Type 2 Diabetes in a Real-World Setting.

Debmalya Sanyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.